HCA Healthcare (NYSE:HCA) Price Target Lowered to $530.00 at Stephens

HCA Healthcare (NYSE:HCA) had its target price reduced by Stephens from $560.00 to $530.00 in a report issued on Monday, MarketBeat Ratings reports. Stephens currently has an overweight rating on the stock.

HCA has been the topic of several other research reports. Oppenheimer lowered their target price on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research note on Monday. Weiss Ratings reaffirmed a “buy (b)” rating on shares of HCA Healthcare in a research note on Friday, March 27th. The Goldman Sachs Group lifted their target price on shares of HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. KeyCorp reduced their price target on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a report on Monday. Finally, Truist Financial reduced their price target on HCA Healthcare from $546.00 to $535.00 and set a “buy” rating on the stock in a report on Monday. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $523.09.

HCA Healthcare Stock Up 3.2%

Shares of HCA opened at $446.38 on Monday. HCA Healthcare has a 52-week low of $326.14 and a 52-week high of $556.52. The firm’s fifty day moving average is $503.58 and its two-hundred day moving average is $486.01. The stock has a market cap of $99.80 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 1.45 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same period last year, the firm earned $6.45 EPS. The company’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts anticipate that HCA Healthcare will post 30.15 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s payout ratio is 10.99%.

Insider Activity at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 1,694 shares of the business’s stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the sale, the executive vice president directly owned 8,853 shares in the company, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the sale, the senior vice president owned 44,379 shares in the company, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 15,214 shares of company stock valued at $7,797,595 in the last quarter. Corporate insiders own 1.50% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

Institutional investors have recently bought and sold shares of the company. Holos Integrated Wealth LLC acquired a new position in HCA Healthcare in the 4th quarter valued at about $29,000. Palisade Asset Management LLC acquired a new position in HCA Healthcare in the 3rd quarter valued at about $26,000. Ares Financial Consulting LLC acquired a new position in HCA Healthcare in the 4th quarter valued at about $31,000. MCF Advisors LLC grew its position in HCA Healthcare by 213.0% in the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock valued at $34,000 after acquiring an additional 49 shares in the last quarter. Finally, Aventura Private Wealth LLC acquired a new position in shares of HCA Healthcare during the fourth quarter worth about $34,000. 62.73% of the stock is owned by institutional investors and hedge funds.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Management reaffirmed FY2026 guidance and expects 2%–3% volume growth while acknowledging headwinds, which supports the company’s forward earnings outlook. HCA projects 2%-3% volume growth
• Positive Sentiment: HCA says improvements in its revenue‑cycle operations are boosting cash collections and helping offset rising denials/underpayments — a near‑term margin and cash‑flow positive. Revenue cycle paying dividends
• Positive Sentiment: Leadership hire: Cynthia Cifuentes‑Finkel will become SVP of Marketing & Corporate Affairs (effective June 8), adding senior marketing/communications capacity ahead of growth initiatives. HCA names new SVP
• Neutral Sentiment: Local operations: a new HCA Florida Gainesville hospital is preparing to open next month — incremental local growth but limited immediate impact on enterprise results. Gainesville hospital opening
• Neutral Sentiment: Market commentary pieces and index signals are discussing healthcare positioning; useful for macro context but not company‑specific catalysts. Market update
• Negative Sentiment: Multiple analysts reduced price targets and trimmed forecasts after Q1 results (despite an in‑line EPS), signaling more cautious near‑term sentiment. Firms lowering targets include Stephens, Oppenheimer, TD Cowen, Leerink, RBC and Truist. Analysts slash forecasts
• Negative Sentiment: Q1 dynamics: EPS roughly in‑line but seasonal volume softness, shifting payer mix and projected ACA/exchange pressures (company cites a $600M–$900M headwind range) are weighing on near‑term revenue and margin expectations. Q1 deep dive
• Negative Sentiment: Financing: HCA filed a proposed public offering of senior notes to raise proceeds for general corporate purposes (may include refinancing). New debt issuance could modestly pressure credit metrics depending on size and terms. Proposed senior notes offering

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.